Literature DB >> 3871916

Similarity between the vaccinia virus 19K early protein and epidermal growth factor.

A H Reisner.   

Abstract

An analysis of the 1,217-amino acid residue sequence of the precursor of mouse epidermal growth factor (mEGF) revealed regions of considerable similarity with bovine factor X, a blood coagulation factor. Similarities of mEGF itself with factor X, pancreatic secretory trypsin inhibitor and, most strikingly, transforming growth factor I (TGF-I) have been observed. On the basis of the comparisons described here, it seems that the presumptive 140-residue 19K early protein (relative molecular mass (Mr) 19,000) of vaccinia virus from residues 40-91 shows an overall identity of 36% (19/53 residues) with both mEGF and urogastrone (human epidermal growth factor, hEGF); a single deletion is assumed for vaccinia virus 19K protein which allows the six Cys residues (positions 45-80) to be aligned with those of mEGF or hEGF. This protein is encoded in the 10.3-kilobase (kb) inverted terminal repeat. Because it is an early protein with an EGF-like central portion, the 19K vaccinia virus protein may have an autocrine function and may be required for DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871916     DOI: 10.1038/313801a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha.

Authors:  W Chang; C Upton; S L Hu; A F Purchio; G McFadden
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Deletion of the vaccinia virus growth factor gene reduces virus virulence.

Authors:  R M Buller; S Chakrabarti; J A Cooper; D R Twardzik; B Moss
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Characterization of vaccinia virus growth factor biosynthetic pathway with an antipeptide antiserum.

Authors:  W Chang; J G Lim; I Hellström; L E Gentry
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene.

Authors:  P L Earl; E V Jones; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters.

Authors:  L Yuen; B Moss
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

7.  Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene.

Authors:  J F Rodriguez; J S Kahn; M Esteban
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Conserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species.

Authors:  T W Wright; P J Simpson-Haidaris; F Gigliotti; A G Harmsen; C G Haidaris
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Bacteriophage PRD1 DNA polymerase: evolution of DNA polymerases.

Authors:  G H Jung; M C Leavitt; J C Hsieh; J Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

10.  Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1.

Authors:  S Michelson; J Alcami; S J Kim; D Danielpour; F Bachelerie; L Picard; C Bessia; C Paya; J L Virelizier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.